Patent application number | Description | Published |
20110212962 | P38 MAP KINASE INHIBITORS - There are provided inter alia compounds of formula (I) wherein R | 09-01-2011 |
20110269800 | P38 MAP KINASE INHIBITORS - There is provided a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, including all tautomers thereof, compositions comprising the same, use of said compound and compositions for treatment, in particular for the treatment of asthma and COPD, and processes for the preparation of said compound. | 11-03-2011 |
20110294812 | P38 MAP KINASE INHIBITORS - The invention relates to compounds of formula (I): | 12-01-2011 |
20110312963 | P38 MAP KINASE INHIBITORS - The present disclosure relates to compounds of formula (I): | 12-22-2011 |
20120136031 | P38MAP KINASE INHIBITOR - The present invention relates to a compound of formula (I): | 05-31-2012 |
20120244120 | INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION - The present invention relates inter alia to the treatment or prevention of influenza virus infection (including subtypes influenza A virus, influenza B virus, avian strain H5N1, A/H1N1, H3N2 and/or pandemic influenza) using compounds which inhibit the activity of p59-HCK and to a method of screening for a candidate drug substance intended to prevent or treat influenza virus infection in a subject, said method comprising identifying a test substance capable of inhibiting p59-HCK activity. | 09-27-2012 |
20130012512 | P38 MAP kinase inhibitors - There are provided inter alia compounds of formula (I) | 01-10-2013 |
20130040995 | NOVEL COMPOUNDS - There is provided inter alia a compound of formula (I): | 02-14-2013 |
20130102607 | UREIDO-PYRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF RHINOVIRUS INFECTIONS - Medicinal use The disclosure relates to compounds of formula (I) for use in the treatment or prophylaxis of respiratory syncitial virus (RSV) infection in particular viral exacerbation of a respiratory disorder such as bronchitis, asthma, COPD and/or cystic fibrosis, methods of treating or preventing RSV infection employing said compounds or pharmaceutical composition comprising the same. | 04-25-2013 |
20130123260 | Methods - The disclosure relates to compounds of formula (I) for use in the treatment or prophylaxis of rhinovirus infection, methods of treating or preventing rhinovirus infection employing said compounds or pharmaceutical composition comprising the same. The disclosure also relates to compounds of formula (I) for use in the treatment or prophylaxis of exacerbation of respiratory disorders (such as asthma, COPD, bronchitis and/or cystic fibrosis) by rhinovirus infection. | 05-16-2013 |
20140114064 | P38 MAP KINASE INHIBITORS - There are provided inter alia compounds of formula (I) | 04-24-2014 |